‘Astonishing Results’ Or ‘Outrageous’ Claims? Peter Thomas Roth Fighting Bicoastal Class Actions
Executive Summary
Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.
You may also be interested in...
This ‘Small Type’ Hyaluronic Acid Claim Could Sink Bath & Body Works In Federal Class Action
Plaintiffs against Bath & Body Works, LLC allege published data “prove that hyaluronic acid attracts and retains only a fraction of its weight in water from the atmosphere,” rendering claims on the back panel of the iconic retailer’s Hyaluronic Acid products false and misleading.
Adore Settles With Nationwide Class Over Apple Stem Cell Anti-Aging Claims
The estimated $700,000 settlement puts to rest allegations that the luxury skin-care firm deceived consumers with claims about its PhytoCellTec ingredient’s ability to slow the aging process. G.M. Collin, another PhytoCellTec Malus Domestica user, also appears to have reached a deal with plaintiffs in litigation challenging its anti-aging claims.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.